Novasec Funds the Future with New Renewable Energy Investment Platform
Today, Novasec Ltd. announced the launch of its investment platform, which connects investors with unique opportunities in the fast-growing renewable energy sector. Through a careful project selection process, Novasec’s platform combines the renewable energy sector with digital securities, providing investors the potential for lower-risk, competitive returns.
“Novasec is proud to help fund the future of the energy industry, offering accredited investors access to attractive renewables opportunities,” says Michael Tishler, CEO and Co-Founder. “Our team of professionals brings together experience from across the financial services, private equity and renewable energy industries, which has allowed us to build a unique end-to-end platform that will benefit both investors and our partners. We are thrilled to embark on this journey and get to work towards our first project.”
Novasec’s focus on renewable energy stems from the sector’s significant potential. The growing global movement toward power sources like wind and solar is undeniable. With 137 countries committed to reducing between 80% to 90% of their carbon emissions, the global community’s adoption of new sources of energy is here to stay. As renewable energy becomes consistently cheaper than fossil fuels and the number of state subsidies and feed-in tariffs decreases, there is an opportunity for private investors to benefit from projects that were previously available only to large scale institutional investors.
Novasec has developed an end-to-end platform for financing renewable energy projects through private placements for accredited investors, with Novasec managing the entire investment process. The goal is to maximize returns, minimize risk, increase availability and incorporate the benefits of the flexibility, liquidity, transparency, fractionalization and embedded compliance provided by digital securities.
Crucially, Novasec locates the right projects for investors, conducting in-depth due diligence, establishing the legal and tax structure for each project the company agrees to finance and ensuring that a capable local development team is in place. Then, the company sets the fundraising and distribution strategy, creating a smooth, efficient and transparent operation. With its careful selection and vetting process, meticulous project structure and innovative platform for renewable investment, Novasec is going beyond traditional project financing and funding the future of renewable investment.
About Novasec Ltd.
Novasec is a Tel Aviv-based innovative investment platform for the fast-growing renewable energy sector. Bringing together a rigorous process for project selection, along with the advantages created by digital securities, Novasec is funding the future with a new type of financing model.
To learn more about Novasec, please visit https://www.novasec.io.
Montieth & Company
About Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Announces Reimbursement of Cystic Fibrosis Medicines SYMDEKO® (tezacaftor/ivacaftor and ivacaftor) for Eligible Patients Ages 12 and Older, and ORKAMBI® (lumacaftor/ivacaftor) in Children Ages 2 to 5, With Certain CFTR Mutations in Australia19.10.2019 23:29:00 CEST | Press release
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) today announced that SYMDEKO® (tezacaftor/ivacaftor and ivacaftor) is reimbursed in Australia for people with cystic fibrosis (CF) ages 12 years and older who are homozygous for the F508del mutation or who have one copy of the F508del mutation and another responsive residual function (RF) mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. People with CF who have one copy of the F508del mutation and another responsive RF mutation in the CFTR gene will have access to a medicine for the cause of their CF for the first time. In addition, ORKAMBI® (lumacaftor/ivacaftor) is now also reimbursed for the treatment of children with CF ages 2 to 5 who have two copies of the F508del mutation in the CFTR gene. Patients over the age of 6 have already been able to access ORKAMBI® in Australia since October 2018. Following previously received positive recommendations from the Pharmaceutical Benefits Advisory Committee (PB
A&D Resources utvider i Norden19.10.2019 12:57:00 CEST | Press release
A&D Resources, den autoriserte distributøren for Hogan Assessments i Danmark og Benelux-landene, utvider forretningsdriften til Finland, Norge og Sverige, noe som gjøre det til den fremste Hogan-distributøren i regionen. Denne pressemeldingen inneholder multimedia. Se hele pressemeldingen her: https://www.businesswire.com/news/home/20191019005034/no/ A&D spesialiserer seg i evaluering og utvikling av enkeltpersoner, grupper og organisasjoner, og er ansett som den fremste evalueringsvirksomheten i Danmark. Denne utvidelsen i Norden kan i stor grad tilskrives organisasjonens suksesshistorie i den omliggende regionen og også på grunn av dens arbeid globalt. «Vi er heldige som har et sterkt omdømme innenfor vår bransje, enten det er i Danmark, Benelux eller utover, og det er fordi vi leverer», sier Hans Ove Dahl, administrerende direktør i A&D. «Vi mener at hvis du bygger opp et talentfullt team ved å bruke Hogans evalueringer, som er allment betraktet som de mest prediktive evalueringene
EURid Launches New Eligibility Criteria19.10.2019 04:30:00 CEST | Press release
The top-level internet domain .eu is the eighth largest country code extension on the internet and, as of October 2019, we have more than 3.6 million registrations spread out across Europe. Since its launch in 2006, only companies and individuals residing within the EU and EEA member states have been eligible to register the .eu domain name. However, striving to meet the needs of an ever-changing digital environment, the eligibility criteria for the registration of .eu domain name has now been extended to all EU citizens living around the world. With millions of Europeans living around the world – our hope is to provide these individuals, living far from their native lands, with a personal online platform through which they can share their stories with families and friends back home. “We are excited to be able to extend the registration criteria to EU citizens around the world. The .eu domain is now closer to your ambitions, achievements and dreams. It is the bridge connecting you to y
ams to Launch New Takeover Offer for OSRAM at EUR 41.00 Per Share With Minimum Acceptance Threshold of 55%18.10.2019 17:16:00 CEST | Press release
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION ams (SIX: AMS), a leading worldwide supplier of high performance sensor solutions, announces that it intends to launch a new all-cash takeover offer for OSRAM Licht AG ("OSRAM") for 100% of the share capital of OSRAM at a price of EUR 41.00 per share ("Offer"). The Offer which represents a premium of 42% to the undisturbed OSRAM share price of EUR 28.92 as of 2 July 2019 will be launched by ams Offer GmbH, a newly incorporated, wholly owned subsidiary of ams. ams is the largest shareholder in OSRAM with a direct shareholding of 19.99% which ams will not exceed outside of the Offer. As a result of ams' shareholder position, ams has lowered the minimum acceptance threshold to 55%. Winning way forward for ams and OSRAM The combination of ams and OSRAM allows ams to create a global leader in sensor solutio
Resecurity Appoints Selene Giupponi Managing Director of Resecurity Europe18.10.2019 15:38:00 CEST | Press release
Resecurity, a cybersecurity company that delivers in-depth analysis layered on top of the most comprehensive, exclusive sets of data from the Deep and Dark Web, announces that Selene Giupponi has joined as Managing Director and will be based in Italy. A digital forensics expert, Selene adds significant value to Resecurity’s operations in Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191018005415/en/ Resecurity Appoints Selene Giupponi Managing Director of Resecurity Europe (Photo: Business Wire) Selene has extensive expertise in digital forensics and is often called as an expert witness regarding digital and mobile forensics on domestic and international cases, investigations and court trials. She is a specialized IT trainer in Italy and teaches digital, mobile, cloud and mainframe forensics, cybercrime and information security at various Italian universities. “Selene brings a depth of experience to our team and we
Secure-24 Completes Acquisition of Symmetry Corporation18.10.2019 14:20:00 CEST | Press release
NTT Ltd., the newly formed, world-leading global technology services provider, and Symmetry Holding Inc. (Symmetry), a U.S.-based leading provider of SAP managed services, today announced that Secure-24 Intermediate Holdings, Inc. (Secure-24), part of the Managed Services division of NTT Ltd., has completed the acquisition of Symmetry Corporation effective October 17, 2019. “The powerful business combination of Secure-24 and Symmetry leverages the strengths of both companies around Secure-24’s foundation of delivering managed IT operations, application hosting and cloud services to enterprises worldwide,” said Mike BeDell, Chief Executive Officer, Secure-24. “As we begin to integrate Symmetry’s portfolio into Secure-24’s portfolio, through a shared vision, we look forward to providing even greater value that accelerates our clients’ business success.” Symmetry, headquartered in Brookfield, Wisconsin, will expand the scale of SAP managed services capabilities of Secure-24 and bring new